Nabla
Making drug development a true design discipline
Nabla is a biotech company that combines generative AI drug design with large-scale, human-relevant wet and dry lab testing to make drug discovery more precise and reliable. Their integrated platform owns the data, AI, and lab systems as a single engine to design medicines with the properties patients need. They partner with leading pharmaceutical companies to bring these designed drugs to market.
Nabla combines generative de novo drug design with large-scale human-relevant testing and integrated dry/wet-lab systems into one engine to turn discovery into a designable, engineerable process.
pharmaceutical companies and drug developers
Background.
- Status
- launched
- Business model
- unknown
- Company
- Nabla
Similar projects.
Editorial take on the space this project sits in — momentum signals, adjacent moves, our call on whether the wedge is real. Get pinged when we publish a new read or when the landscape shifts.
Have a take on this space?
Tell us what you’d build differently, where you think the incumbents miss, or what we’ve gotten wrong about this project. Comments + reactions are coming soon.